data_2lwc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lwc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -117.58 -26.7 6.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -1.153 . . . . 1.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.265 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 19.4 p90 -124.12 -29.7 3.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -1.173 . . . . 1.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.448 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 38.6 mmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.211 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' MET . 18.4 p90 -118.86 -37.73 3.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -1.153 . . . . 1.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 1.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.3 p90 -131.0 -43.38 1.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -1.135 . . . . 1.0 110.298 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.196 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 5' ' ' MET . 23.6 p90 -115.91 -31.88 5.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.33 -1.1 . . . . 1.0 110.106 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.578 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 10.9 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.6 p90 -128.77 -43.7 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -1.131 . . . . 1.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 2.2 mmt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.4 p90 -118.95 -43.12 2.67 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -1.205 . . . . 1.0 110.318 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.518 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 4.1 ppp? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.223 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.413 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' MET . 35.3 p90 -111.62 -40.84 4.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -1.142 . . . . 1.0 110.2 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.603 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.252 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 12.1 p90 -128.74 -45.77 1.3 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -1.211 . . . . 1.0 110.215 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.158 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.56 -1.416 . . . . 1.0 109.56 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.9 p90 -110.97 -28.43 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 1.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.452 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.4 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CD2' ' N ' ' A' ' 5' ' ' MET . 20.4 p90 -120.24 -43.72 2.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 1.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.504 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.35 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 5' ' ' MET . 31.5 p90 -113.92 -41.49 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -1.112 . . . . 1.0 110.351 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.566 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.271 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.8 p90 -123.39 -32.68 3.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.256 -1.144 . . . . 1.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 5' ' ' MET . 16.4 p90 -124.99 -33.23 2.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -1.168 . . . . 1.0 110.336 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.571 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.646 -1.382 . . . . 1.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.5 p90 -125.55 -37.66 2.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -1.158 . . . . 1.0 110.25 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.562 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.225 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 11.5 p90 -131.27 -38.73 1.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -1.138 . . . . 1.0 110.239 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 1.0 109.618 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' MET . 32.4 p90 -110.43 -41.05 4.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.223 -1.163 . . . . 1.0 110.223 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.585 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.037 -0.982 . . . . 1.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.522 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.1 p90 -118.18 -43.32 2.74 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.291 -1.123 . . . . 1.0 110.197 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.522 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.255 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 1.0 109.713 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CD2' ' N ' ' A' ' 5' ' ' MET . 21.9 p90 -118.49 -42.77 2.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 1.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.505 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 1.0 109.703 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 5' ' ' MET . 24.7 p90 -98.19 -37.32 9.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -1.182 . . . . 1.0 110.409 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.631 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.325 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.2 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.27 38.19 3.31 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.28 -24.24 8.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -117.58 -26.7 6.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -1.153 . . . . 1.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.265 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.469 ' O ' ' CE1' ' A' ' 4' ' ' PHE . 49.8 t80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.22 0.533 . . . . 1.0 110.207 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.88 36.69 4.22 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.21 -9.81 57.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 1' ' ' TYR . 19.4 p90 -124.12 -29.7 3.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -1.173 . . . . 1.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.448 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 38.6 mmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.211 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.262 0.553 . . . . 1.0 110.221 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.97 29.97 5.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.8 -37.93 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 1.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' MET . 18.4 p90 -118.86 -37.73 3.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -1.153 . . . . 1.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 1.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.431 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 1.1 t80 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.278 0.561 . . . . 1.0 110.13 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -126.91 36.45 2.63 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.54 -28.7 3.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.3 p90 -131.0 -43.38 1.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -1.135 . . . . 1.0 110.298 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.196 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.481 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.292 0.568 . . . . 1.0 110.149 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -127.77 37.61 2.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.22 -38.09 1.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 5' ' ' MET . 23.6 p90 -115.91 -31.88 5.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.33 -1.1 . . . . 1.0 110.106 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.578 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 10.9 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.551 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 1.4 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.223 0.535 . . . . 1.0 110.199 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.87 15.33 5.93 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.84 -29.13 13.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 1' ' ' TYR . 10.6 p90 -128.77 -43.7 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -1.131 . . . . 1.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 2.2 mmt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.425 ' CD2' ' N ' ' A' ' 3' ' ' GLY . 75.4 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.217 0.532 . . . . 1.0 110.2 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.502 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -104.62 37.21 3.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' N ' ' CD2' ' A' ' 1' ' ' TYR . . . -95.73 -20.83 25.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.4 p90 -118.95 -43.12 2.67 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -1.205 . . . . 1.0 110.318 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.518 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 4.1 ppp? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.223 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 19.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.236 0.541 . . . . 1.0 110.214 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.494 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -112.63 39.48 2.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.41 -19.93 14.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.413 . . . . 1.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' MET . 35.3 p90 -111.62 -40.84 4.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -1.142 . . . . 1.0 110.2 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.603 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.252 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.41 ' O ' ' CE1' ' A' ' 4' ' ' PHE . 16.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.252 0.548 . . . . 1.0 110.269 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -100.49 35.01 5.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 1.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.95 -10.44 69.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 12.1 p90 -128.74 -45.77 1.3 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -1.211 . . . . 1.0 110.215 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.48 ' CG ' ' HA2' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.158 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.27 0.557 . . . . 1.0 110.225 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.19 24.08 3.12 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.52 -40.28 4.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.56 -1.416 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.9 p90 -110.97 -28.43 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 1.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.452 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.4 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.309 0.576 . . . . 1.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.511 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -113.56 35.86 4.32 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.566 -1.414 . . . . 1.0 109.566 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.45 -14.75 49.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CD2' ' N ' ' A' ' 5' ' ' MET . 20.4 p90 -120.24 -43.72 2.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 1.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.511 ' CG ' ' HA2' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.35 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.275 0.559 . . . . 1.0 110.186 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.8 41.65 2.18 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.11 -17.45 18.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 5' ' ' MET . 31.5 p90 -113.92 -41.49 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -1.112 . . . . 1.0 110.351 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.566 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.271 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.324 0.583 . . . . 1.0 110.195 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.83 31.52 1.75 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.34 -34.85 2.81 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.8 p90 -123.39 -32.68 3.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.256 -1.144 . . . . 1.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.267 0.556 . . . . 1.0 110.156 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.92 29.37 1.69 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.636 -1.386 . . . . 1.0 109.636 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.54 -29.64 4.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 5' ' ' MET . 16.4 p90 -124.99 -33.23 2.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -1.168 . . . . 1.0 110.336 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.571 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.248 0.547 . . . . 1.0 110.222 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.47 27.46 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.464 -1.454 . . . . 1.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.57 -23.31 7.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.646 -1.382 . . . . 1.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 1' ' ' TYR . 17.5 p90 -125.55 -37.66 2.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -1.158 . . . . 1.0 110.25 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.562 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.225 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.295 0.569 . . . . 1.0 110.279 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.92 18.67 2.16 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.37 -30.59 8.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 11.5 p90 -131.27 -38.73 1.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -1.138 . . . . 1.0 110.239 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.5 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.286 0.565 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.37 42.16 2.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.43 -23.65 7.87 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 1.0 109.618 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' MET . 32.4 p90 -110.43 -41.05 4.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.223 -1.163 . . . . 1.0 110.223 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.585 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.037 -0.982 . . . . 1.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 18.4 t80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.294 0.569 . . . . 1.0 110.156 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.8 34.55 4.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.02 -11.95 53.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.522 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.1 p90 -118.18 -43.32 2.74 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.291 -1.123 . . . . 1.0 110.197 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.522 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.255 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.357 0.599 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.87 34.07 5.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.481 . . . . 1.0 109.399 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.14 -21.25 33.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 1.0 109.713 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CD2' ' N ' ' A' ' 5' ' ' MET . 21.9 p90 -118.49 -42.77 2.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 1.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.505 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.55 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 1.5 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.252 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.41 41.94 1.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.85 -40.53 1.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 1.0 109.703 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 5' ' ' MET . 24.7 p90 -98.19 -37.32 9.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -1.182 . . . . 1.0 110.409 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.631 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.325 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -117.58 -26.7 6.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -1.153 . . . . 1.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.265 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 19.4 p90 -124.12 -29.7 3.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -1.173 . . . . 1.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.45 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 38.6 mmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.211 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' MET . 18.4 p90 -118.86 -37.73 3.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -1.153 . . . . 1.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 1.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.3 p90 -131.0 -43.38 1.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -1.135 . . . . 1.0 110.298 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.196 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 5' ' ' MET . 23.6 p90 -115.91 -31.88 5.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.33 -1.1 . . . . 1.0 110.106 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 10.9 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.6 p90 -128.77 -43.7 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -1.131 . . . . 1.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.434 ' HG2' ' CD2' ' A' ' 4' ' ' PHE . 2.2 mmt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.4 p90 -118.95 -43.12 2.67 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -1.205 . . . . 1.0 110.318 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.518 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 4.1 ppp? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.223 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.413 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' MET . 35.3 p90 -111.62 -40.84 4.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -1.142 . . . . 1.0 110.2 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.603 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.252 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 12.1 p90 -128.74 -45.77 1.3 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -1.211 . . . . 1.0 110.215 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.158 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.56 -1.416 . . . . 1.0 109.56 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.9 p90 -110.97 -28.43 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 1.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.452 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.4 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CD2' ' N ' ' A' ' 5' ' ' MET . 20.4 p90 -120.24 -43.72 2.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 1.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.504 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.35 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 5' ' ' MET . 31.5 p90 -113.92 -41.49 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -1.112 . . . . 1.0 110.351 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.566 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.271 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.8 p90 -123.39 -32.68 3.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.256 -1.144 . . . . 1.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 5' ' ' MET . 16.4 p90 -124.99 -33.23 2.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -1.168 . . . . 1.0 110.336 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.571 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.646 -1.382 . . . . 1.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.5 p90 -125.55 -37.66 2.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -1.158 . . . . 1.0 110.25 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.562 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.225 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 11.5 p90 -131.27 -38.73 1.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -1.138 . . . . 1.0 110.239 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 1.0 109.618 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' MET . 32.4 p90 -110.43 -41.05 4.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.223 -1.163 . . . . 1.0 110.223 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.585 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.037 -0.982 . . . . 1.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.522 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.1 p90 -118.18 -43.32 2.74 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.291 -1.123 . . . . 1.0 110.197 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.522 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.255 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 1.0 109.713 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CD2' ' N ' ' A' ' 5' ' ' MET . 21.9 p90 -118.49 -42.77 2.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 1.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.505 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 1.0 109.703 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 5' ' ' MET . 24.7 p90 -98.19 -37.32 9.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -1.182 . . . . 1.0 110.409 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.631 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.325 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.2 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.27 38.19 3.31 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.28 -24.24 8.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -117.58 -26.7 6.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -1.153 . . . . 1.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.265 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.469 ' O ' ' CE1' ' A' ' 4' ' ' PHE . 49.8 t80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.22 0.533 . . . . 1.0 110.207 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.88 36.69 4.22 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.21 -9.81 57.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 1' ' ' TYR . 19.4 p90 -124.12 -29.7 3.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -1.173 . . . . 1.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.45 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 38.6 mmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.211 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.262 0.553 . . . . 1.0 110.221 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.97 29.97 5.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.8 -37.93 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 1.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' MET . 18.4 p90 -118.86 -37.73 3.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -1.153 . . . . 1.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 1.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 1.1 t80 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.278 0.561 . . . . 1.0 110.13 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -126.91 36.45 2.63 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.54 -28.7 3.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.3 p90 -131.0 -43.38 1.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -1.135 . . . . 1.0 110.298 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.196 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.499 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.292 0.568 . . . . 1.0 110.149 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -127.77 37.61 2.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.22 -38.09 1.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 5' ' ' MET . 23.6 p90 -115.91 -31.88 5.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.33 -1.1 . . . . 1.0 110.106 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 10.9 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 1.4 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.223 0.535 . . . . 1.0 110.199 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.87 15.33 5.93 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.84 -29.13 13.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 1' ' ' TYR . 10.6 p90 -128.77 -43.7 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -1.131 . . . . 1.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.434 ' HG2' ' CD2' ' A' ' 4' ' ' PHE . 2.2 mmt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.425 ' CD2' ' N ' ' A' ' 3' ' ' GLY . 75.4 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.217 0.532 . . . . 1.0 110.2 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.512 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -104.62 37.21 3.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' N ' ' CD2' ' A' ' 1' ' ' TYR . . . -95.73 -20.83 25.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.4 p90 -118.95 -43.12 2.67 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -1.205 . . . . 1.0 110.318 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.518 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 4.1 ppp? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.223 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 19.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.236 0.541 . . . . 1.0 110.214 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -112.63 39.48 2.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.41 -19.93 14.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.413 . . . . 1.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' MET . 35.3 p90 -111.62 -40.84 4.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -1.142 . . . . 1.0 110.2 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.603 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.252 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.41 ' O ' ' CE1' ' A' ' 4' ' ' PHE . 16.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.252 0.548 . . . . 1.0 110.269 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.495 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -100.49 35.01 5.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 1.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.95 -10.44 69.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 12.1 p90 -128.74 -45.77 1.3 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -1.211 . . . . 1.0 110.215 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.495 ' CG ' ' HA2' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.158 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.27 0.557 . . . . 1.0 110.225 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.19 24.08 3.12 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.52 -40.28 4.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.56 -1.416 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.9 p90 -110.97 -28.43 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 1.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.452 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.4 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.309 0.576 . . . . 1.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.52 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -113.56 35.86 4.32 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.566 -1.414 . . . . 1.0 109.566 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.45 -14.75 49.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CD2' ' N ' ' A' ' 5' ' ' MET . 20.4 p90 -120.24 -43.72 2.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 1.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.52 ' CG ' ' HA2' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.35 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.275 0.559 . . . . 1.0 110.186 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.8 41.65 2.18 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.11 -17.45 18.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 5' ' ' MET . 31.5 p90 -113.92 -41.49 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -1.112 . . . . 1.0 110.351 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.566 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.271 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.324 0.583 . . . . 1.0 110.195 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.83 31.52 1.75 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.34 -34.85 2.81 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.8 p90 -123.39 -32.68 3.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.256 -1.144 . . . . 1.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.267 0.556 . . . . 1.0 110.156 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.92 29.37 1.69 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.636 -1.386 . . . . 1.0 109.636 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.54 -29.64 4.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 5' ' ' MET . 16.4 p90 -124.99 -33.23 2.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -1.168 . . . . 1.0 110.336 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.571 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.248 0.547 . . . . 1.0 110.222 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.47 27.46 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.464 -1.454 . . . . 1.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.57 -23.31 7.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.646 -1.382 . . . . 1.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 1' ' ' TYR . 17.5 p90 -125.55 -37.66 2.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -1.158 . . . . 1.0 110.25 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.562 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.225 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.295 0.569 . . . . 1.0 110.279 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.92 18.67 2.16 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.37 -30.59 8.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 11.5 p90 -131.27 -38.73 1.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -1.138 . . . . 1.0 110.239 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.5 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.286 0.565 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.37 42.16 2.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.43 -23.65 7.87 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 1.0 109.618 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' MET . 32.4 p90 -110.43 -41.05 4.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.223 -1.163 . . . . 1.0 110.223 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.585 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.037 -0.982 . . . . 1.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 18.4 t80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.294 0.569 . . . . 1.0 110.156 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.8 34.55 4.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.02 -11.95 53.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.522 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.1 p90 -118.18 -43.32 2.74 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.291 -1.123 . . . . 1.0 110.197 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.522 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.255 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.357 0.599 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.407 ' HA2' ' HG3' ' A' ' 5' ' ' MET . . . -109.87 34.07 5.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.481 . . . . 1.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.14 -21.25 33.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 1.0 109.713 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CD2' ' N ' ' A' ' 5' ' ' MET . 21.9 p90 -118.49 -42.77 2.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 1.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.505 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.573 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 1.5 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.252 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.41 41.94 1.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.85 -40.53 1.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 1.0 109.703 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 5' ' ' MET . 24.7 p90 -98.19 -37.32 9.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -1.182 . . . . 1.0 110.409 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.631 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.325 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -117.58 -26.7 6.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -1.153 . . . . 1.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.265 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 19.4 p90 -124.12 -29.7 3.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -1.173 . . . . 1.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.45 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 38.6 mmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.211 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 1.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' MET . 18.4 p90 -118.86 -37.73 3.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -1.153 . . . . 1.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 1.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.3 p90 -131.0 -43.38 1.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -1.135 . . . . 1.0 110.298 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.196 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 5' ' ' MET . 23.6 p90 -115.91 -31.88 5.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.33 -1.1 . . . . 1.0 110.106 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 10.9 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.6 p90 -128.77 -43.7 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -1.131 . . . . 1.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.434 ' HG2' ' CD2' ' A' ' 4' ' ' PHE . 2.2 mmt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.4 p90 -118.95 -43.12 2.67 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -1.205 . . . . 1.0 110.318 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.518 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 4.1 ppp? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.223 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.413 . . . . 1.0 109.569 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' MET . 35.3 p90 -111.62 -40.84 4.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -1.142 . . . . 1.0 110.2 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.603 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.252 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 12.1 p90 -128.74 -45.77 1.3 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -1.211 . . . . 1.0 110.215 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.158 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.56 -1.416 . . . . 1.0 109.56 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.9 p90 -110.97 -28.43 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 1.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.452 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.4 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CD2' ' N ' ' A' ' 5' ' ' MET . 20.4 p90 -120.24 -43.72 2.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 1.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.504 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.35 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 5' ' ' MET . 31.5 p90 -113.92 -41.49 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -1.112 . . . . 1.0 110.351 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.566 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.271 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.8 p90 -123.39 -32.68 3.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.256 -1.144 . . . . 1.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 5' ' ' MET . 16.4 p90 -124.99 -33.23 2.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -1.168 . . . . 1.0 110.336 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.571 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.646 -1.382 . . . . 1.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.5 p90 -125.55 -37.66 2.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -1.158 . . . . 1.0 110.25 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.562 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.225 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 11.5 p90 -131.27 -38.73 1.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -1.138 . . . . 1.0 110.239 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 1.0 109.618 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' MET . 32.4 p90 -110.43 -41.05 4.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.223 -1.163 . . . . 1.0 110.223 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.585 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.037 -0.982 . . . . 1.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.522 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.1 p90 -118.18 -43.32 2.74 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.291 -1.123 . . . . 1.0 110.197 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.522 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.255 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 1.0 109.713 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CD2' ' N ' ' A' ' 5' ' ' MET . 21.9 p90 -118.49 -42.77 2.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 1.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.505 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 1.0 109.703 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 5' ' ' MET . 24.7 p90 -98.19 -37.32 9.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -1.182 . . . . 1.0 110.409 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.631 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.325 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.2 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.27 38.19 3.31 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.28 -24.24 8.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.54 -1.424 . . . . 1.0 109.54 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -117.58 -26.7 6.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.24 -1.153 . . . . 1.0 110.205 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.948 -1.025 . . . . 1.0 110.265 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.469 ' O ' ' CE1' ' A' ' 4' ' ' PHE . 49.8 t80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.22 0.533 . . . . 1.0 110.207 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.88 36.69 4.22 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.564 -1.414 . . . . 1.0 109.564 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.21 -9.81 57.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.515 -1.434 . . . . 1.0 109.515 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.469 ' CE1' ' O ' ' A' ' 1' ' ' TYR . 19.4 p90 -124.12 -29.7 3.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.207 -1.173 . . . . 1.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.45 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 38.6 mmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.211 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.262 0.553 . . . . 1.0 110.221 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.97 29.97 5.83 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.8 -37.93 1.96 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 1.0 109.51 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' MET . 18.4 p90 -118.86 -37.73 3.2 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -1.153 . . . . 1.0 110.226 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.136 -0.977 . . . . 1.0 110.24 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 1.1 t80 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.278 0.561 . . . . 1.0 110.13 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -126.91 36.45 2.63 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.54 -28.7 3.91 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 10.3 p90 -131.0 -43.38 1.07 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -1.135 . . . . 1.0 110.298 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.196 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.499 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.292 0.568 . . . . 1.0 110.149 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -127.77 37.61 2.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.581 -1.408 . . . . 1.0 109.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.22 -38.09 1.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 5' ' ' MET . 23.6 p90 -115.91 -31.88 5.61 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.33 -1.1 . . . . 1.0 110.106 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 10.9 mmt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.956 -1.021 . . . . 1.0 110.206 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 1.4 t80 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.223 0.535 . . . . 1.0 110.199 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.87 15.33 5.93 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.84 -29.13 13.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.408 . . . . 1.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 1' ' ' TYR . 10.6 p90 -128.77 -43.7 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.277 -1.131 . . . . 1.0 110.224 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.434 ' HG2' ' CD2' ' A' ' 4' ' ' PHE . 2.2 mmt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.254 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.425 ' CD2' ' N ' ' A' ' 3' ' ' GLY . 75.4 t80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.217 0.532 . . . . 1.0 110.2 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.512 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -104.62 37.21 3.9 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' N ' ' CD2' ' A' ' 1' ' ' TYR . . . -95.73 -20.83 25.47 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.4 p90 -118.95 -43.12 2.67 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -1.205 . . . . 1.0 110.318 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.518 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 4.1 ppp? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.223 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 19.8 t80 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.236 0.541 . . . . 1.0 110.214 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -112.63 39.48 2.85 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.493 -1.443 . . . . 1.0 109.493 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.41 -19.93 14.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.413 . . . . 1.0 109.569 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 5' ' ' MET . 35.3 p90 -111.62 -40.84 4.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.259 -1.142 . . . . 1.0 110.2 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.603 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.001 -0.999 . . . . 1.0 110.252 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.41 ' O ' ' CE1' ' A' ' 4' ' ' PHE . 16.4 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.252 0.548 . . . . 1.0 110.269 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.495 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -100.49 35.01 5.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.419 -1.472 . . . . 1.0 109.419 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.95 -10.44 69.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.75 -1.34 . . . . 1.0 109.75 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 12.1 p90 -128.74 -45.77 1.3 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.142 -1.211 . . . . 1.0 110.215 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.495 ' CG ' ' HA2' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.009 -0.996 . . . . 1.0 110.158 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.27 0.557 . . . . 1.0 110.225 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.19 24.08 3.12 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.52 -40.28 4.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.56 -1.416 . . . . 1.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.9 p90 -110.97 -28.43 8.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -1.087 . . . . 1.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.452 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 3.4 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.023 -0.989 . . . . 1.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.309 0.576 . . . . 1.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.52 ' HA2' ' CG ' ' A' ' 5' ' ' MET . . . -113.56 35.86 4.32 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.566 -1.414 . . . . 1.0 109.566 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.45 -14.75 49.63 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CD2' ' N ' ' A' ' 5' ' ' MET . 20.4 p90 -120.24 -43.72 2.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.311 -1.111 . . . . 1.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.52 ' CG ' ' HA2' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.35 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.275 0.559 . . . . 1.0 110.186 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.8 41.65 2.18 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.11 -17.45 18.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 5' ' ' MET . 31.5 p90 -113.92 -41.49 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -1.112 . . . . 1.0 110.351 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.566 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.271 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.324 0.583 . . . . 1.0 110.195 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.83 31.52 1.75 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.34 -34.85 2.81 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.577 -1.409 . . . . 1.0 109.577 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 5' ' ' MET . 17.8 p90 -123.39 -32.68 3.36 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.256 -1.144 . . . . 1.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.267 0.556 . . . . 1.0 110.156 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.92 29.37 1.69 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.636 -1.386 . . . . 1.0 109.636 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.54 -29.64 4.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 1.0 109.624 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 5' ' ' MET . 16.4 p90 -124.99 -33.23 2.94 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -1.168 . . . . 1.0 110.336 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.571 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.203 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.248 0.547 . . . . 1.0 110.222 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.47 27.46 1.36 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.464 -1.454 . . . . 1.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.57 -23.31 7.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.646 -1.382 . . . . 1.0 109.646 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 1' ' ' TYR . 17.5 p90 -125.55 -37.66 2.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -1.158 . . . . 1.0 110.25 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.562 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.225 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.295 0.569 . . . . 1.0 110.279 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.92 18.67 2.16 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.37 -30.59 8.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 1.0 109.512 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 11.5 p90 -131.27 -38.73 1.19 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.265 -1.138 . . . . 1.0 110.239 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.196 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.5 t80 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.286 0.565 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.37 42.16 2.04 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.518 -1.433 . . . . 1.0 109.518 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -104.43 -23.65 7.87 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.618 -1.393 . . . . 1.0 109.618 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 5' ' ' MET . 32.4 p90 -110.43 -41.05 4.46 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.223 -1.163 . . . . 1.0 110.223 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.585 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.037 -0.982 . . . . 1.0 110.243 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 18.4 t80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.294 0.569 . . . . 1.0 110.156 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.8 34.55 4.17 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.475 -1.45 . . . . 1.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.02 -11.95 53.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.522 ' CD2' ' N ' ' A' ' 5' ' ' MET . 25.1 p90 -118.18 -43.32 2.74 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.291 -1.123 . . . . 1.0 110.197 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.522 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.255 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 10.4 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.357 0.599 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.407 ' HA2' ' HG3' ' A' ' 5' ' ' MET . . . -109.87 34.07 5.67 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.481 . . . . 1.0 109.399 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.14 -21.25 33.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 1.0 109.713 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CD2' ' N ' ' A' ' 5' ' ' MET . 21.9 p90 -118.49 -42.77 2.74 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 1.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.505 ' N ' ' CD2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 117.983 -1.008 . . . . 1.0 110.26 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.573 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 1.5 t80 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.252 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.41 41.94 1.83 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.486 -1.446 . . . . 1.0 109.486 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.85 -40.53 1.18 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 1.0 109.703 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 5' ' ' MET . 24.7 p90 -98.19 -37.32 9.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -1.182 . . . . 1.0 110.409 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.631 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.325 -179.894 . . . . . . . . 2 2 . 1 stop_ save_